Stephen P. Juraschek, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypotension, Orthostatic | 28 | 2024 | 255 | 15.320 |
Why?
|
| Hypertension | 80 | 2024 | 8480 | 10.700 |
Why?
|
| Uric Acid | 19 | 2023 | 765 | 6.460 |
Why?
|
| Blood Pressure | 76 | 2024 | 8551 | 6.040 |
Why?
|
| Diet, Sodium-Restricted | 12 | 2023 | 287 | 5.200 |
Why?
|
| Blood Pressure Determination | 23 | 2023 | 633 | 4.820 |
Why?
|
| Sodium, Dietary | 13 | 2023 | 418 | 4.540 |
Why?
|
| Gout | 12 | 2023 | 573 | 4.400 |
Why?
|
| Antihypertensive Agents | 24 | 2024 | 2047 | 4.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 8 | 2023 | 236 | 3.550 |
Why?
|
| Hyperuricemia | 8 | 2023 | 211 | 3.210 |
Why?
|
| Accidental Falls | 17 | 2023 | 1062 | 2.640 |
Why?
|
| Hypotension | 6 | 2023 | 880 | 2.580 |
Why?
|
| Dizziness | 6 | 2023 | 251 | 2.410 |
Why?
|
| Dietary Carbohydrates | 8 | 2021 | 906 | 2.110 |
Why?
|
| Atherosclerosis | 13 | 2023 | 3444 | 2.050 |
Why?
|
| Sodium | 9 | 2023 | 1623 | 1.990 |
Why?
|
| Natriuretic Peptide, Brain | 9 | 2023 | 1573 | 1.890 |
Why?
|
| Syncope | 6 | 2023 | 429 | 1.820 |
Why?
|
| Cardiovascular Diseases | 24 | 2024 | 15161 | 1.680 |
Why?
|
| Lactic Acid | 5 | 2020 | 1132 | 1.560 |
Why?
|
| Posture | 4 | 2023 | 958 | 1.540 |
Why?
|
| Vitamins | 12 | 2023 | 1621 | 1.480 |
Why?
|
| Glomerular Filtration Rate | 12 | 2021 | 2170 | 1.460 |
Why?
|
| Renal Insufficiency, Chronic | 12 | 2023 | 2208 | 1.420 |
Why?
|
| Glycemic Index | 5 | 2021 | 395 | 1.370 |
Why?
|
| Troponin T | 4 | 2023 | 753 | 1.350 |
Why?
|
| Peptide Fragments | 9 | 2023 | 5096 | 1.320 |
Why?
|
| Physical Fitness | 5 | 2015 | 733 | 1.300 |
Why?
|
| Patient Selection | 9 | 2023 | 4216 | 1.280 |
Why?
|
| Metoprolol | 2 | 2018 | 93 | 1.230 |
Why?
|
| Nutrition Surveys | 15 | 2023 | 1660 | 1.190 |
Why?
|
| Cross-Over Studies | 12 | 2021 | 2032 | 1.180 |
Why?
|
| Middle Aged | 108 | 2023 | 213367 | 1.170 |
Why?
|
| Cystatin C | 8 | 2016 | 250 | 1.170 |
Why?
|
| beta 2-Microglobulin | 5 | 2016 | 315 | 1.150 |
Why?
|
| Potassium | 4 | 2023 | 1336 | 1.140 |
Why?
|
| Intramolecular Oxidoreductases | 4 | 2013 | 109 | 1.060 |
Why?
|
| Dietary Supplements | 15 | 2023 | 3297 | 1.050 |
Why?
|
| Diabetes Mellitus | 11 | 2023 | 5755 | 1.040 |
Why?
|
| Male | 129 | 2024 | 350027 | 1.030 |
Why?
|
| Humans | 196 | 2024 | 744220 | 1.020 |
Why?
|
| Female | 137 | 2024 | 380197 | 1.010 |
Why?
|
| Lipocalins | 4 | 2013 | 170 | 1.000 |
Why?
|
| Amlodipine | 3 | 2020 | 83 | 1.000 |
Why?
|
| Aged | 87 | 2024 | 163253 | 0.970 |
Why?
|
| Midodrine | 1 | 2024 | 22 | 0.960 |
Why?
|
| Adult | 79 | 2024 | 214035 | 0.950 |
Why?
|
| Deoxyglucose | 4 | 2019 | 337 | 0.930 |
Why?
|
| Exercise Tolerance | 4 | 2017 | 770 | 0.930 |
Why?
|
| Illusions | 1 | 2023 | 60 | 0.900 |
Why?
|
| Blood Proteins | 2 | 2020 | 1123 | 0.870 |
Why?
|
| Dietary Fiber | 3 | 2021 | 760 | 0.850 |
Why?
|
| Metformin | 4 | 2022 | 835 | 0.850 |
Why?
|
| C-Reactive Protein | 6 | 2023 | 3778 | 0.850 |
Why?
|
| Thyroid Diseases | 3 | 2022 | 378 | 0.840 |
Why?
|
| Hyperglycemia | 4 | 2017 | 1372 | 0.840 |
Why?
|
| Fractures, Bone | 5 | 2023 | 1947 | 0.820 |
Why?
|
| Vitamin D | 10 | 2023 | 3222 | 0.820 |
Why?
|
| Albuminuria | 4 | 2021 | 683 | 0.810 |
Why?
|
| Ascorbic Acid | 3 | 2022 | 650 | 0.800 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2024 | 257 | 0.780 |
Why?
|
| Dietary Proteins | 5 | 2020 | 963 | 0.760 |
Why?
|
| Overweight | 7 | 2021 | 2370 | 0.750 |
Why?
|
| Serum Albumin | 3 | 2020 | 676 | 0.740 |
Why?
|
| Osmolar Concentration | 1 | 2021 | 683 | 0.740 |
Why?
|
| Troponin I | 2 | 2023 | 619 | 0.740 |
Why?
|
| Hyperthyroidism | 1 | 2022 | 295 | 0.740 |
Why?
|
| Hypothyroidism | 2 | 2022 | 659 | 0.730 |
Why?
|
| Food-Processing Industry | 1 | 2019 | 15 | 0.720 |
Why?
|
| Thirst | 1 | 2020 | 38 | 0.720 |
Why?
|
| Diuresis | 1 | 2020 | 116 | 0.720 |
Why?
|
| Patient Isolation | 1 | 2020 | 100 | 0.710 |
Why?
|
| Urine | 1 | 2021 | 370 | 0.710 |
Why?
|
| Obesity | 15 | 2023 | 12742 | 0.700 |
Why?
|
| Exercise Test | 7 | 2021 | 2075 | 0.690 |
Why?
|
| Food Industry | 1 | 2019 | 68 | 0.680 |
Why?
|
| Blood Glucose | 9 | 2022 | 6259 | 0.680 |
Why?
|
| Prehypertension | 2 | 2016 | 61 | 0.660 |
Why?
|
| Basal Metabolism | 1 | 2020 | 168 | 0.660 |
Why?
|
| Ramipril | 1 | 2018 | 95 | 0.640 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2017 | 30 | 0.610 |
Why?
|
| Creatinine | 5 | 2016 | 1919 | 0.610 |
Why?
|
| Awards and Prizes | 1 | 2022 | 375 | 0.610 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2020 | 177 | 0.610 |
Why?
|
| Risk Factors | 42 | 2024 | 72280 | 0.610 |
Why?
|
| Energy Intake | 3 | 2020 | 2148 | 0.610 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 320 | 0.610 |
Why?
|
| Gout Suppressants | 2 | 2017 | 166 | 0.590 |
Why?
|
| Mortality | 5 | 2017 | 2864 | 0.590 |
Why?
|
| Weight Loss | 8 | 2023 | 2622 | 0.590 |
Why?
|
| Kidney Diseases | 4 | 2018 | 2147 | 0.580 |
Why?
|
| Sodium Chloride, Dietary | 4 | 2023 | 281 | 0.570 |
Why?
|
| Kidney | 5 | 2021 | 7183 | 0.550 |
Why?
|
| Nutrition Policy | 1 | 2020 | 488 | 0.550 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 961 | 0.540 |
Why?
|
| Proportional Hazards Models | 16 | 2021 | 12355 | 0.540 |
Why?
|
| United States | 38 | 2023 | 69867 | 0.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2022 | 11732 | 0.530 |
Why?
|
| Behavior Therapy | 1 | 2021 | 867 | 0.530 |
Why?
|
| Sodium Chloride | 1 | 2017 | 625 | 0.520 |
Why?
|
| Pilot Projects | 6 | 2021 | 8321 | 0.510 |
Why?
|
| Fruit | 4 | 2023 | 1142 | 0.510 |
Why?
|
| Vegetables | 4 | 2022 | 1182 | 0.510 |
Why?
|
| Diet | 6 | 2023 | 7937 | 0.480 |
Why?
|
| Residence Characteristics | 4 | 2018 | 2050 | 0.480 |
Why?
|
| Forecasting | 6 | 2019 | 2949 | 0.470 |
Why?
|
| Dementia | 3 | 2023 | 2518 | 0.470 |
Why?
|
| Randomized Controlled Trials as Topic | 11 | 2021 | 9960 | 0.460 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 933 | 0.450 |
Why?
|
| Incidence | 18 | 2022 | 20945 | 0.450 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2016 | 262 | 0.450 |
Why?
|
| Stroke | 4 | 2023 | 9981 | 0.440 |
Why?
|
| Albumins | 1 | 2015 | 569 | 0.440 |
Why?
|
| Cholecalciferol | 5 | 2023 | 537 | 0.440 |
Why?
|
| Central Nervous System Stimulants | 1 | 2021 | 1148 | 0.430 |
Why?
|
| Potassium, Dietary | 2 | 2023 | 96 | 0.420 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3132 | 0.420 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3239 | 0.420 |
Why?
|
| Risk Assessment | 12 | 2022 | 23337 | 0.410 |
Why?
|
| Telemedicine | 3 | 2024 | 2872 | 0.400 |
Why?
|
| Clinical Trials as Topic | 3 | 2023 | 7908 | 0.400 |
Why?
|
| Aged, 80 and over | 23 | 2023 | 57768 | 0.390 |
Why?
|
| Schistosoma | 1 | 2010 | 17 | 0.390 |
Why?
|
| Hepatomegaly | 1 | 2010 | 85 | 0.380 |
Why?
|
| Coronary Disease | 3 | 2023 | 6078 | 0.370 |
Why?
|
| Pandemics | 3 | 2021 | 8387 | 0.370 |
Why?
|
| Schistosomiasis | 1 | 2010 | 62 | 0.370 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1889 | 0.370 |
Why?
|
| Prevalence | 15 | 2023 | 15226 | 0.370 |
Why?
|
| Chlorthalidone | 2 | 2020 | 19 | 0.370 |
Why?
|
| Splenomegaly | 1 | 2010 | 190 | 0.370 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2266 | 0.360 |
Why?
|
| Double-Blind Method | 10 | 2023 | 12035 | 0.350 |
Why?
|
| Atenolol | 2 | 2020 | 100 | 0.350 |
Why?
|
| Prospective Studies | 17 | 2023 | 53280 | 0.350 |
Why?
|
| Hepatitis C | 1 | 2020 | 1591 | 0.350 |
Why?
|
| Medication Adherence | 1 | 2020 | 2062 | 0.330 |
Why?
|
| Body Weight | 1 | 2020 | 4666 | 0.330 |
Why?
|
| Primary Prevention | 4 | 2022 | 1167 | 0.330 |
Why?
|
| Vitamin D Deficiency | 4 | 2023 | 1343 | 0.320 |
Why?
|
| Hypertension, Portal | 1 | 2010 | 220 | 0.320 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2020 | 226 | 0.320 |
Why?
|
| Cross-Sectional Studies | 16 | 2024 | 25043 | 0.300 |
Why?
|
| Time Factors | 10 | 2021 | 40063 | 0.300 |
Why?
|
| Cryopreservation | 1 | 2012 | 670 | 0.290 |
Why?
|
| Cause of Death | 5 | 2019 | 3584 | 0.280 |
Why?
|
| Lung Diseases | 2 | 2015 | 1885 | 0.280 |
Why?
|
| Asymptomatic Diseases | 2 | 2020 | 552 | 0.270 |
Why?
|
| Fatty Acids, Volatile | 3 | 2022 | 101 | 0.270 |
Why?
|
| Feeding Behavior | 1 | 2017 | 3188 | 0.260 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 1240 | 0.250 |
Why?
|
| Life Style | 4 | 2022 | 3835 | 0.250 |
Why?
|
| Phenotype | 2 | 2022 | 16365 | 0.240 |
Why?
|
| Nurses | 2 | 2011 | 2461 | 0.240 |
Why?
|
| Health Services Needs and Demand | 2 | 2011 | 1411 | 0.240 |
Why?
|
| Physicians | 1 | 2022 | 4564 | 0.240 |
Why?
|
| Sphygmomanometers | 1 | 2023 | 15 | 0.240 |
Why?
|
| Comorbidity | 6 | 2020 | 10387 | 0.240 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5138 | 0.220 |
Why?
|
| Fructosamine | 2 | 2012 | 14 | 0.220 |
Why?
|
| Young Adult | 12 | 2022 | 56436 | 0.220 |
Why?
|
| Cognition | 1 | 2020 | 6765 | 0.220 |
Why?
|
| Michigan | 4 | 2017 | 350 | 0.220 |
Why?
|
| Vital Signs | 1 | 2023 | 141 | 0.210 |
Why?
|
| American Heart Association | 2 | 2024 | 1056 | 0.210 |
Why?
|
| Body Mass Index | 4 | 2021 | 12718 | 0.210 |
Why?
|
| Diet, Vegetarian | 1 | 2023 | 174 | 0.210 |
Why?
|
| Supine Position | 1 | 2022 | 204 | 0.210 |
Why?
|
| Research Design | 4 | 2023 | 5987 | 0.210 |
Why?
|
| Medical History Taking | 2 | 2022 | 783 | 0.200 |
Why?
|
| Thyrotropin | 2 | 2022 | 850 | 0.200 |
Why?
|
| Pharmacists | 1 | 2024 | 247 | 0.200 |
Why?
|
| Losartan | 1 | 2023 | 299 | 0.200 |
Why?
|
| Thyroxine | 2 | 2022 | 666 | 0.200 |
Why?
|
| Aging | 1 | 2020 | 8661 | 0.200 |
Why?
|
| Uromodulin | 1 | 2021 | 46 | 0.200 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39045 | 0.200 |
Why?
|
| Treatment Outcome | 14 | 2021 | 63119 | 0.190 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 11728 | 0.190 |
Why?
|
| Maryland | 1 | 2021 | 276 | 0.190 |
Why?
|
| Fats, Unsaturated | 1 | 2020 | 21 | 0.190 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 151 | 0.190 |
Why?
|
| Clothing | 1 | 2021 | 92 | 0.190 |
Why?
|
| Heart Rate | 3 | 2018 | 4092 | 0.190 |
Why?
|
| Triglycerides | 2 | 2020 | 2453 | 0.190 |
Why?
|
| Lisinopril | 1 | 2020 | 54 | 0.180 |
Why?
|
| Natriuresis | 1 | 2020 | 124 | 0.180 |
Why?
|
| Flatulence | 1 | 2019 | 20 | 0.180 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15070 | 0.180 |
Why?
|
| Medicare | 4 | 2023 | 6566 | 0.180 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2021 | 423 | 0.170 |
Why?
|
| Prognosis | 7 | 2023 | 29050 | 0.170 |
Why?
|
| Craniocerebral Trauma | 1 | 2023 | 482 | 0.170 |
Why?
|
| Exercise | 5 | 2023 | 5615 | 0.170 |
Why?
|
| Independent Living | 2 | 2023 | 568 | 0.170 |
Why?
|
| Electronics | 1 | 2020 | 322 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2014 | 6535 | 0.170 |
Why?
|
| Prescriptions | 1 | 2021 | 387 | 0.160 |
Why?
|
| Caloric Restriction | 1 | 2021 | 302 | 0.160 |
Why?
|
| Dyspepsia | 1 | 2019 | 115 | 0.160 |
Why?
|
| Teaching Rounds | 1 | 2022 | 253 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 4251 | 0.160 |
Why?
|
| Bradycardia | 1 | 2020 | 305 | 0.160 |
Why?
|
| Hypoglycemic Agents | 3 | 2020 | 2875 | 0.160 |
Why?
|
| Vitamin E | 1 | 2022 | 869 | 0.160 |
Why?
|
| Renin | 1 | 2020 | 642 | 0.150 |
Why?
|
| Gait | 1 | 2023 | 793 | 0.150 |
Why?
|
| Computer Security | 1 | 2019 | 263 | 0.150 |
Why?
|
| Cohort Studies | 10 | 2022 | 40559 | 0.150 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2021 | 370 | 0.150 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 700 | 0.150 |
Why?
|
| Phosphorus, Dietary | 1 | 2016 | 20 | 0.150 |
Why?
|
| Sex Factors | 4 | 2019 | 10396 | 0.150 |
Why?
|
| Office Visits | 1 | 2021 | 598 | 0.150 |
Why?
|
| Insulin | 3 | 2018 | 6583 | 0.150 |
Why?
|
| Health Surveys | 3 | 2019 | 4037 | 0.140 |
Why?
|
| Delivery of Health Care | 3 | 2021 | 5319 | 0.140 |
Why?
|
| Pressure | 1 | 2020 | 1203 | 0.140 |
Why?
|
| Spironolactone | 1 | 2019 | 382 | 0.140 |
Why?
|
| Electronic Health Records | 4 | 2023 | 4463 | 0.140 |
Why?
|
| Cholesterol, LDL | 3 | 2022 | 2355 | 0.140 |
Why?
|
| Risk | 3 | 2020 | 9685 | 0.130 |
Why?
|
| Protein Precursors | 1 | 2020 | 1154 | 0.130 |
Why?
|
| Hospitalization | 4 | 2023 | 10262 | 0.130 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 13990 | 0.130 |
Why?
|
| Age Factors | 7 | 2021 | 18367 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3256 | 0.130 |
Why?
|
| Aldosterone | 1 | 2020 | 877 | 0.130 |
Why?
|
| Heart Failure | 4 | 2021 | 10905 | 0.120 |
Why?
|
| Goals | 1 | 2020 | 706 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 10949 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2021 | 5076 | 0.120 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 1677 | 0.120 |
Why?
|
| Scotland | 1 | 2014 | 155 | 0.120 |
Why?
|
| Eating | 1 | 2021 | 1538 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2020 | 1814 | 0.110 |
Why?
|
| Logistic Models | 3 | 2021 | 13409 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2021 | 2014 | 0.110 |
Why?
|
| Brain | 1 | 2020 | 26413 | 0.110 |
Why?
|
| HIV Infections | 1 | 2020 | 16718 | 0.110 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3611 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2020 | 1062 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2020 | 861 | 0.110 |
Why?
|
| Bayes Theorem | 4 | 2022 | 2309 | 0.110 |
Why?
|
| Systole | 3 | 2020 | 957 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2019 | 1531 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2019 | 1172 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2020 | 1379 | 0.110 |
Why?
|
| HIV | 1 | 2020 | 1604 | 0.110 |
Why?
|
| Drug Monitoring | 1 | 2018 | 956 | 0.110 |
Why?
|
| Longevity | 1 | 2020 | 1069 | 0.100 |
Why?
|
| Employment | 2 | 2010 | 1129 | 0.100 |
Why?
|
| Cardiology | 1 | 2023 | 1668 | 0.100 |
Why?
|
| Community-Based Participatory Research | 1 | 2013 | 214 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2012 | 1344 | 0.100 |
Why?
|
| Motivation | 1 | 2021 | 1971 | 0.100 |
Why?
|
| Freezing | 1 | 2012 | 303 | 0.100 |
Why?
|
| Sciatica | 1 | 2012 | 98 | 0.100 |
Why?
|
| Epidemics | 1 | 2017 | 523 | 0.100 |
Why?
|
| Praziquantel | 1 | 2010 | 25 | 0.100 |
Why?
|
| Counseling | 1 | 2019 | 1523 | 0.100 |
Why?
|
| Insulin Resistance | 2 | 2016 | 3863 | 0.100 |
Why?
|
| Health Status | 2 | 2015 | 4034 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15294 | 0.100 |
Why?
|
| Adolescent | 7 | 2023 | 85759 | 0.090 |
Why?
|
| Anthelmintics | 1 | 2010 | 62 | 0.090 |
Why?
|
| Blood Specimen Collection | 1 | 2012 | 246 | 0.090 |
Why?
|
| Myocardial Revascularization | 1 | 2014 | 841 | 0.090 |
Why?
|
| Diskectomy | 1 | 2012 | 206 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2017 | 906 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 19907 | 0.090 |
Why?
|
| Boston | 1 | 2023 | 9311 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 788 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4396 | 0.090 |
Why?
|
| Dyslipidemias | 2 | 2015 | 849 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 1737 | 0.090 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 2576 | 0.090 |
Why?
|
| Radiculopathy | 1 | 2012 | 197 | 0.090 |
Why?
|
| Coronary Artery Disease | 3 | 2021 | 6489 | 0.090 |
Why?
|
| Rest | 1 | 2014 | 901 | 0.090 |
Why?
|
| Glycosylation | 1 | 2012 | 1126 | 0.090 |
Why?
|
| Atrial Fibrillation | 3 | 2021 | 5034 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2279 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 15538 | 0.080 |
Why?
|
| Propranolol | 1 | 2010 | 502 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 1031 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3047 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2024 | 3746 | 0.080 |
Why?
|
| Ultrasonography, Doppler | 1 | 2010 | 458 | 0.080 |
Why?
|
| Frail Elderly | 2 | 2024 | 693 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2019 | 21752 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3509 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2016 | 2017 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2017 | 4217 | 0.080 |
Why?
|
| Neoplasms | 2 | 2021 | 21672 | 0.080 |
Why?
|
| Aspirin | 1 | 2019 | 3282 | 0.070 |
Why?
|
| Linear Models | 1 | 2017 | 5953 | 0.070 |
Why?
|
| Homocysteine | 1 | 2010 | 647 | 0.070 |
Why?
|
| Cholesterol | 1 | 2016 | 2911 | 0.070 |
Why?
|
| Software | 1 | 2021 | 4442 | 0.070 |
Why?
|
| Fasting | 1 | 2012 | 1591 | 0.070 |
Why?
|
| Walking | 2 | 2024 | 1180 | 0.070 |
Why?
|
| Inflammation | 2 | 2023 | 10634 | 0.070 |
Why?
|
| Proteinuria | 1 | 2009 | 657 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7281 | 0.070 |
Why?
|
| Feces | 2 | 2022 | 1402 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2017 | 9849 | 0.060 |
Why?
|
| Reference Values | 2 | 2023 | 4982 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2011 | 3001 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2018 | 4041 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2011 | 3913 | 0.060 |
Why?
|
| Folic Acid | 1 | 2010 | 1300 | 0.060 |
Why?
|
| Nursing Staff, Hospital | 1 | 2006 | 346 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2006 | 501 | 0.050 |
Why?
|
| Sterilization, Reproductive | 1 | 2022 | 21 | 0.050 |
Why?
|
| Radiography | 1 | 2013 | 7022 | 0.050 |
Why?
|
| Retrospective Studies | 7 | 2020 | 77426 | 0.050 |
Why?
|
| Butyrates | 1 | 2022 | 163 | 0.050 |
Why?
|
| Heartburn | 1 | 2021 | 68 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2021 | 135 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2538 | 0.050 |
Why?
|
| Drug Dosage Calculations | 1 | 2020 | 114 | 0.050 |
Why?
|
| Indapamide | 1 | 2019 | 2 | 0.040 |
Why?
|
| Gliclazide | 1 | 2019 | 4 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7784 | 0.040 |
Why?
|
| Hunger | 1 | 2021 | 198 | 0.040 |
Why?
|
| Perindopril | 1 | 2019 | 12 | 0.040 |
Why?
|
| Baroreflex | 1 | 2020 | 146 | 0.040 |
Why?
|
| Permeability | 1 | 2022 | 738 | 0.040 |
Why?
|
| Hand Strength | 1 | 2022 | 448 | 0.040 |
Why?
|
| Hyperkalemia | 1 | 2021 | 218 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2019 | 284 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 4559 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 1744 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 671 | 0.040 |
Why?
|
| Digestive System | 1 | 2019 | 251 | 0.040 |
Why?
|
| Contraception | 1 | 2022 | 359 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 425 | 0.040 |
Why?
|
| Appetite | 1 | 2020 | 243 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 791 | 0.040 |
Why?
|
| Physical Examination | 1 | 2024 | 1238 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 12805 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2019 | 494 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2019 | 213 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2018 | 356 | 0.040 |
Why?
|
| Hepatitis C Antibodies | 1 | 2017 | 145 | 0.040 |
Why?
|
| Child | 4 | 2023 | 77679 | 0.040 |
Why?
|
| Smoking | 1 | 2014 | 8986 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2021 | 643 | 0.040 |
Why?
|
| Metabolic Equivalent | 1 | 2016 | 14 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2011 | 5102 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 2021 | 921 | 0.030 |
Why?
|
| Equipment Design | 1 | 2023 | 3582 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
| Microvessels | 1 | 2019 | 544 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 1372 | 0.030 |
Why?
|
| Data Mining | 1 | 2019 | 537 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 2216 | 0.030 |
Why?
|
| Body Composition | 1 | 2023 | 2400 | 0.030 |
Why?
|
| Proteins | 1 | 2009 | 6101 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 2018 | 1092 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2958 | 0.030 |
Why?
|
| California | 2 | 2008 | 1402 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 2015 | 263 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3201 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2012 | 214 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2012 | 183 | 0.030 |
Why?
|
| Disease Progression | 2 | 2020 | 13280 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2023 | 1797 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4419 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2016 | 2297 | 0.020 |
Why?
|
| Health Promotion | 1 | 2023 | 2205 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 879 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 683 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2732 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2020 | 4199 | 0.020 |
Why?
|
| Calibration | 1 | 2012 | 816 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2624 | 0.020 |
Why?
|
| Health Behavior | 1 | 2021 | 2636 | 0.020 |
Why?
|
| Social Class | 1 | 2018 | 1999 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2759 | 0.020 |
Why?
|
| Animals | 3 | 2022 | 168788 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 6485 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2017 | 2902 | 0.020 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2009 | 187 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3300 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20123 | 0.020 |
Why?
|
| Licensure, Nursing | 1 | 2006 | 5 | 0.020 |
Why?
|
| Nursing Administration Research | 1 | 2006 | 21 | 0.020 |
Why?
|
| Population Growth | 1 | 2006 | 52 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2019 | 5008 | 0.020 |
Why?
|
| Regional Health Planning | 1 | 2006 | 97 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2016 | 2684 | 0.020 |
Why?
|
| Population Density | 1 | 2006 | 196 | 0.020 |
Why?
|
| Population Dynamics | 1 | 2008 | 302 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12961 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 6991 | 0.020 |
Why?
|
| Lung | 1 | 2023 | 9852 | 0.020 |
Why?
|
| Mice | 2 | 2022 | 81178 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10250 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35423 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2019 | 3311 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12244 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2013 | 2616 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2023 | 40992 | 0.010 |
Why?
|
| Workload | 1 | 2006 | 850 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2006 | 1147 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8090 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 29142 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9147 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3591 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4371 | 0.010 |
Why?
|